Início
Mercados
Gráficos e ideias
Algo
Notícias
Market
Corretoras
Baixar
Calendário econômico
Sinais de Negociação
Terminal web
Heatmap
Pressione
/
para pesquisar: @user, $symbol, ...
Pesquisar
Login
Criar uma conta
Português
English
Русский
中文
Español
日本語
Deutsch
한국어
Français
Italiano
Türkçe
CNSP
#5159
CNS Pharmaceuticals, Inc. Common Stock
2.6
4
USD
+8.64%
Setor:
Cuidados de saúde
Base:
USD
Moeda do lucro:
USD
Faixa diária
Faixa anual
Mudança diária
+8.64%
Mudança mensal
+5.60%
Mudança em 6 meses
-72.36%
Mudança anual
+120.00%
Fechamento anterior
2.4
3
Abrir
2.6
4
Bid
Ask
Mínimo
2.6
4
High
2.6
4
Volume
1
Mercados
Ações
Cuidados de saúde
CNSP
Abrir gráfico completo
Financials
Visão geral
Relatórios
Estatísticas
Trimestral
Ano
Valor
2020
2021
2022
2023
2024
2025
TTM
Key stats
Total common shares outstanding
28.11
44.48
74.21
354.5
245.37 K
811.45 K
—
Valuation ratios
Enterprise value
31.44 M
23.5 M
-3.72 M
12.41 M
11.59 M
-2.61 M
-18.59 M
Price to earnings ratio
—
—
-0.24
-0.24
-0.15
-0.15
-0.14
Price to sales ratio
—
—
-1 164.33
164.89
12.11 K
-909.61
—
Price to cash flow ratio
—
—
-0.34
-0.32
-0.13
-0.17
-0.24
Price to book ratio
—
—
0.45
-1.01
0.37
0.51
0.57
Enterprise value to EBITDA ratio
-3.38
-1.71
0.21
-0.64
-0.76
0.18
1.28
Profitability ratios
Return on assets %
-0.6
-1.6
-1.17
-11.08
-1.71
-1.84
-1.44
Return on equity %
-0.68
-2.12
-1.88
4.25
-2.41
-3.5
-2.21
Return on invested capital %
-6 290.05
-4 005
-4 206.49
-11.53 K
-15.3 K
-10.5 K
—
Gross margin %
100
—
100
100
100
100
—
Operating margin %
597.26 K
—
490.75 K
-69.39 K
-7.84 M
624.72 K
—
EBITDA margin %
596.66 K
—
490.47 K
-69.27 K
-7.84 M
624.67 K
—
Net margin %
597.47 K
—
490.97 K
-69.33 K
-7.82 M
619.4 K
—
Liquidity ratios
Quick ratio
—
—
—
—
—
—
—
Current ratio
8.13
3.5
2.55
0.26
3.43
1.98
22.95
Inventory turnover
—
—
—
—
—
—
—
Asset turnover
-0
0
-0
0
0
-0
-0
Solvency ratios
Debt to assets ratio
0.03
0.04
0.03
0.18
0.04
0.04
0.06
Debt to equity ratio
0.03
0.06
0.05
-0.07
0.05
0.07
0.1
Long term debt to total assets ratio
0.03
0.04
0.03
0.18
0.04
0.04
0.06
Long term debt to total equity ratio
0.03
0.06
0.05
-0.07
0.05
0.07
0.1
Per share metrics
Operating cash flow per share
—
—
-232.6 K
-112.6 K
-537.25
-31.15
-39.48
EBIT per share
—
—
-336.41 K
-150.01 K
-467.82
-36.06
-44.93
EBITDA per share
—
—
-336.15 K
-149.98 K
-467.72
-36.05
-44.92
Total debt per share
—
—
9 031.88
2 395.35
10.24
0.74
2.05
Cash per share
—
—
221.53 K
4 369.53
202.85
16.24
124.09
Net current asset value per share
—
—
276.81 K
12.67 K
271.82
18.28
137.25
Tangible book value per share
—
—
179.17 K
-35.29 K
193.91
10.2
111.67
Working capital per share
—
—
168.41 K
-36.17 K
192.58
9.03
108.52
Book value per share
—
—
179.17 K
-35.29 K
193.91
10.2
111.67
Notícias
CNS Pharmaceuticals muda foco para ativos de neurologia e oncologia
CNS Pharmaceuticals shifts focus to neurology, oncology assets
CNS Pharmaceuticals nomeia Lynne Kelley como diretora médica
CNS Pharmaceuticals names Lynne Kelley as chief medical officer
CNS Pharmaceuticals appoints three new executives to leadership team
CNS Pharmaceuticals’ new CEO outlines strategic overhaul
Corero Network Security anuncia melhorias em sua plataforma de proteção contra DDoS
Corero Network Security reports DDoS protection platform enhancements
Ações da CNS Pharmaceuticals caem após saída do CEO
CNS Pharmaceuticals stock falls after CEO steps down
CNS Pharmaceuticals appoints Rami Levin as new CEO, replacing Climaco
Acionistas da CNS Pharmaceuticals aprovam aumento de ações e eleição do conselho